Literature DB >> 28834443

Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.

Chen-Jiang Wu1, Yu-Dong Zhang1, Mei-Ling Bao2, Hai Li2, Xiao-Ning Wang1, Xi-Sheng Liu1, Hai-Bin Shi1.   

Abstract

OBJECTIVE: The purpose of this study was to investigate whether diffusion kurtosis imaging (DKI) is useful for predicting upgrades in Gleason score (GS) in biopsy-proven prostate cancer with a GS of 6.
MATERIALS AND METHODS: A total of 46 patients with biopsy-proven GS 6 prostate cancer, 3-T DWI results, and surgical pathologic results were retrospectively included in the study. DWI data were postprocessed with monoexponential and DK models to quantify the apparent diffusion coefficient (ADC), apparent diffusion for gaussian distribution (Dapp), and apparent kurtosis coefficient (Kapp). The volume of the lesions, prostate-specific antigen (PSA) level, and diffusion variables (ADCmin, Dappmin, Kappmax, ADCmean, Dappmean, and Kappmean) were evaluated. PSA and DKI were combined as a parameter in a logistic regression model. The utility of these parameters in predicting an upgrade in GS was analyzed with ROC regression.
RESULTS: The rate of GS upgrade was 50.0% (23/46). The GS upgrade group had significantly lower ADCmin (p = 0.007), ADC mean (p = 0.003), D appmin (p < 0.001), and Dappmean (p = 0.001) values and significantly higher Kappmax (p = 0.003), Kappmean (p = 0.005), and PSA (p = 0.004) values than the group that did not have an upgrade. Among single parameters, Kappmax had the highest ROC AUC value (0.819, p < 0.05), and among all the parameters and models, PSA-Kappmax had the highest AUC (0.868, p < 0.05) and Youden index (0.6522).
CONCLUSION: The results showed that DKI may help in prediction of GS upgrade in biopsy-proven GS 6 prostate cancer. The comprehensive consideration of DKI and PSA may be a promising approach to predicting GS upgrade.

Entities:  

Keywords:  Gleason score; diffusion kurtosis imaging; prostate cancer; upgrading

Mesh:

Substances:

Year:  2017        PMID: 28834443     DOI: 10.2214/AJR.16.17781

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

Review 1.  Emerging MR methods for improved diagnosis of prostate cancer by multiparametric MRI.

Authors:  Durgesh Kumar Dwivedi; Naranamangalam R Jagannathan
Journal:  MAGMA       Date:  2022-07-22       Impact factor: 2.533

2.  Comparison of Diffusion Kurtosis Imaging and Amide Proton Transfer Imaging in the Diagnosis and Risk Assessment of Prostate Cancer.

Authors:  Huijia Yin; Dongdong Wang; Ruifang Yan; Xingxing Jin; Ying Hu; Zhansheng Zhai; Jinhui Duan; Jian Zhang; Kaiyu Wang; Dongming Han
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

3.  Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.

Authors:  Doo Yong Chung; Dong Hoon Koh; Hyeok Jun Goh; Min Seok Kim; Jong Soo Lee; Won Sik Jang; Young Deuk Choi
Journal:  BMC Cancer       Date:  2018-11-01       Impact factor: 4.430

4.  Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.

Authors:  Mengyan Hou; Kai Song; Jipeng Ren; Kaiyu Wang; Jinxia Guo; Yongchao Niu; Zhenyu Li; Dongming Han
Journal:  BMC Cancer       Date:  2022-01-20       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.